R. Kent Jr McGaughy - Jun 10, 2021 Form 4 Insider Report for REATA PHARMACEUTICALS INC (RETA)

Role: Director, 10%+ Owner
Signature: /s/ R. Kent McGaughy, Jr.
Stock symbol: RETA
Transactions as of: Jun 10, 2021
Transactions value $: $57,436
Form type: 4
Date filed: 6/14/2021, 05:25 PM
Next filing: Oct 19, 2021
SEC: View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	RETA	Stock Option (right to buy)	Award	$0	+5K		$0.00	5K	Jun 10, 2021	Class A common stock	5K	$146.01	Direct	F1
transaction	RETA	Stock Option (right to buy)	Award	$57.4K	+690		$83.24	690	Jun 10, 2021	Class A common stock	690	$146.01	Direct	F2, F3

Showing 1 to 2 of 2 entries

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The options vest in 4 equal installments on September 10, 2021, December 10, 2021, March 10, 2022, and June 10, 2022, subject to continued service through each vesting date.
F2	The options vest in the following installments: 172 shares on September 10, 2021, 172 shares on December 10, 2021, 173 shares on March 10, 2022, and 173 shares on June 10, 2022, respectively, subject to continued service through each vesting date.
F3	This option was issued to the reporting person pursuant to the Reata Non-Employee Director Compensation Policy in lieu of director fees of $57,500.